The FDA has cleared the CellFX® System from Pulse Biosciences, Inc. for dermatologic procedures requiring ablation and resurfacing of the skin, and a...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market,...
Austrian medical aesthetic products manufacturer Croma-Pharma has established a joint venture with China National Biotech Group Company (CNBG) to market its HA dermal filler Princess Volume and other...
Endo International plc announced that it received U.S. Food and Drug Administration (FDA) approval of Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate to...
Cynosure announced the U.S., European and Australian launch of the Elite iQ™ platform, the next generation of the Elite+™ Aesthetic Workstation that allows for...
Evolus enrolled its first patient in a clinical study evaluating an “extra-strength” dose for extended duration of Jeuveau (prabotulinumtoxinA-xvfs). Evolus is the first neurotoxin product...